NCT00990444View on ClinicalTrials.gov

A Two Part Study of Peroral Insulin in Type 2 Diabetes

PHASE1/PHASE2SuspendedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

September 30, 2010

Study Completion Date

December 31, 2010

Conditions
Diabetes Mellitus
Interventions
DRUG

Insulin in Dextran Matrix

Fixed dose capsule with 100 IU of insulin in dextran matrix. Investigational drug or placebo are administered in conjunction with food intake on a background of metformin.

Trial Locations (1)

17176

Karolinska Trial Alliance, Phase I Unit, Stockholm

Sponsors
All Listed Sponsors
lead

Bows Pharmaceuticals AG

INDUSTRY